| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/04/2004 | CN1517361A Diosgenin butanedioic acid monoester derivative and its preparation method and application |
| 08/04/2004 | CN1517360A Diosgenin amino and ester derivative and its preparation method and application |
| 08/04/2004 | CN1517126A Drug compastion with thrombolysis, anti-inflammatory and cell protective function |
| 08/04/2004 | CN1517122A Medicine for treating coronary heart disease and its preparation method |
| 08/04/2004 | CN1517118A 竹提取物及其制备方法和应用 Bamboo extract and its preparation method and application |
| 08/04/2004 | CN1517117A Chinese medicine combined with acupoint treatment for curing hypertension etc. disease |
| 08/04/2004 | CN1517114A Oral medicine santong powder for treating arteriosclerosis and its manufacturing method |
| 08/04/2004 | CN1517109A Radically treating 'heart, brain, blovd vessel' disease |
| 08/04/2004 | CN1517107A Chinese herbal medicine pill for invigorating premordial energy and treating coronary disease |
| 08/04/2004 | CN1517100A External use medicinal composition for softening and dredging pyramis arteriosclerosis and its preparation method |
| 08/04/2004 | CN1517096A Application of bamboo leaf flavone in preparation of medicine |
| 08/04/2004 | CN1517094A Monosialic acid tetrahexose ganglioside liposome complex preparation |
| 08/04/2004 | CN1517088A Ginkgo leaf extract injection and its preparation method |
| 08/04/2004 | CN1517086A Medical use of poly hydroxy flavone derivatives |
| 08/04/2004 | CN1160359C Dithiepino [6,5-b] pyridines, and related compsns. and methods for preparing and use |
| 08/04/2004 | CN1160356C Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 08/04/2004 | CN1160343C Aminothiazole inhibitors of cyclin dependent protein kinasses of cells |
| 08/04/2004 | CN1160338C N-[4-(3-chloro-4-fluoro-phenylamino)-7-(-3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, irreversible inihibotr of tyrosine kinases |
| 08/04/2004 | CN1160333C Ester of pipperidinemethanol and their use as prodrugs of the 5HT2A receptor antagonist MDL 110,907 |
| 08/04/2004 | CN1160323C New benzenesulfonylamine derivatives, process for preparating them and pharmaceutical compositions containing them |
| 08/04/2004 | CN1160309C Alkyloxyamino substitued fluorenones and their use as protein kinase C inhibitors |
| 08/04/2004 | CN1160098C Medicine for treating myocardial infarction and angina pectoris |
| 08/04/2004 | CN1160097C Health-care tea for lowering blood pressure |
| 08/04/2004 | CN1160076C Pharmaceutical composition comprising bisphosphonic acid |
| 08/04/2004 | CN1160068C Inihibition of lipoprotein oxidation |
| 08/04/2004 | CN1160067C Ginkgo lactone capsule and its prepn. method |
| 08/04/2004 | CN1160066C Preparing process of freeze dried ginkgolactone injection |
| 08/04/2004 | CN1159984C Prophylactic dietary supplement based on milk |
| 08/03/2004 | US6770778 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters |
| 08/03/2004 | US6770678 Warming (methylsulfonyl substituted-)-benzoylguanidine salt solution to accelerate dissolution; filtration, high speed freeze drying |
| 08/03/2004 | US6770676 Dicarboxylic acid derivatives |
| 08/03/2004 | US6770661 Aryl substituted pyridines and their use |
| 08/03/2004 | US6770660 Method for inhibiting platelet aggregation |
| 08/03/2004 | US6770656 Amine derivatives for the treatment of apoptosis |
| 08/03/2004 | US6770651 A2B adenosine receptor antagonists |
| 08/03/2004 | US6770647 Osteoporosis; rheumatic diseases |
| 08/03/2004 | US6770643 Inhibit protein kinases |
| 08/03/2004 | US6770634 Stimulate mammalian coronary vasodilatation for therapeutic purposes and imaging the heart |
| 08/03/2004 | US6770626 Amino acid sequence from certain regions of tissue growth factor-beta super family serine-threonine kinase receptors |
| 08/03/2004 | US6770624 Heart failure following myocardial infarction is treated by administration of an angiotensin ii inhibitor for 10 weeks, followed by administration of a growth hormone |
| 08/03/2004 | US6770620 Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders |
| 08/03/2004 | US6770619 Lung surfactant compositions with dynamic swelling behavior |
| 08/03/2004 | US6770455 Preparation, use and medicaments containing ribonucleotide polypeptides or their molecular-biological equivalent structures and/or parts and/or derivatives |
| 08/03/2004 | US6770267 Methods of treating periodontal disease |
| 08/03/2004 | CA2233457C Pharmaceutical angiostatic dipeptide compositions and methods of use thereof |
| 08/03/2004 | CA2136836C Piperidinyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension |
| 08/03/2004 | CA2127542C Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 08/03/2004 | CA2110161C Medetomidine preparations for transdermal administration |
| 07/29/2004 | WO2004063380A1 Series of recombinant adeno-associated virus useful for inducing rnai pathway and gene therapy |
| 07/29/2004 | WO2004063365A1 NOVEL USE OF COMPOUND HAVING TGFβ-INHIBITORY ACTIVITY |
| 07/29/2004 | WO2004063221A1 Metastin derivative and use thereof |
| 07/29/2004 | WO2004063202A1 Fused furan compound |
| 07/29/2004 | WO2004063191A1 Pyridine derivatives useful for inhibiting sodium/calcium exchange system |
| 07/29/2004 | WO2004063184A1 Thiophene derivative ppar modulators |
| 07/29/2004 | WO2004063180A1 Substituted heterocyclic compounds |
| 07/29/2004 | WO2004063167A1 Blood-brain barrier disruption inhibitors |
| 07/29/2004 | WO2004063166A1 Heterocyclic ppar modulators |
| 07/29/2004 | WO2004063165A1 A pyrazole derivative as ppar modulator |
| 07/29/2004 | WO2004063148A1 Indenoncarboxylic acids derivatives and their use for the treatment of and preventing diabetes and dyslipidaemia |
| 07/29/2004 | WO2004062686A2 Therapeutic use of modulators of notch |
| 07/29/2004 | WO2004062657A1 Acylated 4-amidino- and 4-guanidinobenzylamines for the inhibition of plasma kallikrein |
| 07/29/2004 | WO2004062592A2 2-o sulfatase compositions and related methods |
| 07/29/2004 | WO2004062578A2 Methods for reducing mortality associated with acute myocardial infarction |
| 07/29/2004 | WO2004062557A2 Pharmaceutical combination of telmisartan and atorvastatin for the prophylaxis or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases |
| 07/29/2004 | WO2004062553A2 Affinity screening using “one-bead-one-compound” libraries |
| 07/29/2004 | WO2004050086A8 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |
| 07/29/2004 | WO2004046191A3 Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition angiogenesis |
| 07/29/2004 | WO2004045533A3 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 07/29/2004 | WO2004041296A3 Pharmaceutical composition comprising a tissue factor antagonist and protein c polypeptides |
| 07/29/2004 | WO2004037233A3 Use of glycogen phosphorylase inhibitors for treatment of cardiovascular diseases |
| 07/29/2004 | WO2004037173A3 Method for treating erectile dysfunction and increasing libido in men |
| 07/29/2004 | WO2004035536A3 Azo compounds for type i phototherapy |
| 07/29/2004 | WO2004034959A3 Multiparticulate modified release composition comprising beraprost |
| 07/29/2004 | WO2004026816B1 Aromatic liver x-receptor modulators |
| 07/29/2004 | WO2004026285A3 Compositions and methods for treating heart disease |
| 07/29/2004 | WO2004024153A3 Calcium channel blockers |
| 07/29/2004 | WO2004014913A3 Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors |
| 07/29/2004 | WO2004012686A3 Nitrosated and/or nitrosylated ursodeoxycholic acid compounds, compositions and methods of use |
| 07/29/2004 | WO2004010972A3 Pellicle-resistant gelatin capsule |
| 07/29/2004 | WO2003094861A3 Bis-benzimidazoles and related compounds as potassium channel modulators |
| 07/29/2004 | WO2003090640A3 Microbial cellulose wound dressing for treating chronic wounds |
| 07/29/2004 | WO2003086317A3 Protein a compositions and methods of use |
| 07/29/2004 | WO2003075741A3 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE |
| 07/29/2004 | WO2003068803A3 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 07/29/2004 | WO2003040107A8 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity |
| 07/29/2004 | US20040147904 Methods and devices for delivery of agents to breast milk ducts |
| 07/29/2004 | US20040147773 Process for purifying n2-(1(s)-ethoxycarbonyl -3-phenylpropyl)-n6-thifluoroacetyl-l-lysine |
| 07/29/2004 | US20040147745 Novel compounds and compositions as protease inhibitors |
| 07/29/2004 | US20040147741 Heptadecapeptide nociceptin opioid receptor modulators; pain relievers; synthesis |
| 07/29/2004 | US20040147737 cellulose ether esters of lactic acid and of hydroxyacetic acid; slow-release pharmaceutical preparations |
| 07/29/2004 | US20040147724 for diagnosis/treatment of cancer, myeloproliferative disorders, angiogenesis, obesity, osteoporosis, non-insulin dependent diabetes, lipid metabolism disorder, hypercalcemia, hypercholestrolemia; genetic engineering |
| 07/29/2004 | US20040147600 Mixture of drug with insulin; antidiabetic agents |
| 07/29/2004 | US20040147598 Cardiovascular disorders; angina pectoris |
| 07/29/2004 | US20040147596 Antidiabetic agents; immunology diseases; antiinflammatory agents |
| 07/29/2004 | US20040147589 Indolone derivatives having vascular damaging activity |
| 07/29/2004 | US20040147586 Antiproliferative agents; anticancer agents; glioblastomas; antidiabetic agents; autoimmune disorders; skin disorders; antiarthritic agents; antiinflammatory agents; cardiovascular disorders |
| 07/29/2004 | US20040147576 Cardiovascular disorders; thrombosis; anticoagulants |
| 07/29/2004 | US20040147575 Hypotensive agents; cardiovascular disorders |
| 07/29/2004 | US20040147573 Metalloproteinase inhibitors |
| 07/29/2004 | US20040147571 Substituted oxazoles and thiazoles as hppar alpha agonists |